Protein hydrolysates for oral tolerance

BioFactors

Volumn 12, Issue 1-4, 2000, Pages 147-150

  Lipkowski, A W ^c   Baranowska, B ^a,c   Marczak, E ^a,c   Kwiatkowska Patzer, B ^b,c   Gajkowska, B ^b,c   Walski, M ^b,c  

^a INDUSTRIAL CHEMISTRY RESEARCH INSTITUTE   (Poland)

^b MOSSAKOWSKI MEDICAL RESEARCH CENTRE   (Poland)

^c KYOTO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; PROTEIN HYDROLYSATE;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; CONFERENCE PAPER; CONTROLLED STUDY; DIGESTION; DRUG ACTIVITY; DRUG ISOLATION; FEEDING; HYDROLYSIS; IMMUNIZATION; IMMUNOLOGICAL TOLERANCE; MULTIPLE SCLEROSIS; NONHUMAN; PRIORITY JOURNAL; RAT; SPINAL CORD; SWINE;

ANIMALIA; SUS SCROFA;

EID: 0034492857     PISSN: 09516433     EISSN: None     Source Type: Journal    
DOI: 10.1002/biof.5520120123     Document Type: Conference Paper

References (4)

1. Oral tolerance: Immune mechanisms and treatment of autoimune diseases
2. Suppression of experimental autoimmune encephalomyelitis in the rat by oral administration of spinal cord protein hydrolysate
3. Ultrastructural changes in the central and peripheral nervous system in the rat with experimental allergic encephalomyelitis